Skip to main content
Caplight Logo









5 Prime Sciences

5 Prime Sciences

Private
MontrealHealthcare & Life Scienceshttps://5primesciences.com/

Last Round

Accelerator

May 2, 2024

Momentum

Top 1%

of companies Caplight tracks

Company Overview

5 Prime Sciences is a biotechnology data analytics company that provides human genetics research, bioinformatics services, and AI-driven analytics to accelerate drug development and de-risk pharmaceutical pipelines.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

drug discoverybioinformaticstarget identificationmulti-omicsclinical trial stratificationAI drug discoveryin silico drug discoverygenomicsGWASgenome-wide association studypredictive modelingdrug development pipelinebiotech analyticsclinical de-riskingdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

5 Prime Sciences Comparables

Compare 5 Prime Sciences with similar companies based on industry and business-model similarity.

5 Prime Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
biotx.ai GmbH
86%
Phenomic AI
79%
Ardigen
77%

5 Prime Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 2, 2024

Key People

Founding team and executive leadership

Brent Richards

CEO and Founder (We're Hiring )

Founding Team

5 Prime Sciences Investors

Notable investors and investment history

5 Prime Sciences investors
InvestorRounds
Creative Destruction LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2026

    Grew 40% QoQ from 10 to 14 employees.

  • Aug 22, 2026

    Monthly visitors grew 9394% MoM, from 65 to 6.2K.

5 Prime Sciences Filings

Explore SEC and related filing metadata, where available.

5 Prime Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 5 Prime Sciences's valuation, stock price, and market status.

Is 5 Prime Sciences a public or private company?

5 Prime Sciences is a private company.

What is the current stock price of 5 Prime Sciences?

5 Prime Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is 5 Prime Sciences worth (valuation)?

Valuation information for 5 Prime Sciences is not publicly available.

Can I buy 5 Prime Sciences stock?

5 Prime Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 5 Prime Sciences's last funding round?

5 Prime Sciences's most recent funding round was Accelerator on May 2, 2024.

Who are the main investors in 5 Prime Sciences?

Key investors in 5 Prime Sciences include Creative Destruction Lab.

Will 5 Prime Sciences IPO soon?

No public IPO plans have been announced for 5 Prime Sciences.

How can I track 5 Prime Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 5 Prime Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range13
Year Founded2021
Last FundingMay 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?